Occlutech GmbH notched a win in its long-running patent war with St. Jude Medical (NYSE:STJ) over structural heart implants, saying an Italian court ruled that it doesn’t infringe a portion of a St. Jude patent.
St. Jude inherited the case, involving intravascular occlusion devices, after it acquired AGA Medical for more than $1 billion last year.